| (USD) | Sep 2025 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -15.78M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, BCAB returned -82.1% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -88.8% |
| 1 year | -82.1% |
| 5 years | -99.8% |
| All-time high | $2,655.00 (Feb 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in BCAB would be worth today ›No. BioAtla, Inc. has not paid a dividend in the past 12 months.
BioAtla, Inc. stock trades on NASDAQ under the ticker symbol BCAB.
BioAtla, Inc. is part of the Healthcare sector.
BioAtla, Inc. has a market cap of 5.30M USD, based on the latest quote.
BioAtla, Inc. is expected to report earnings around Nov 12, 2026. That date is an estimate and has not been confirmed by the company.
